| Literature DB >> 27677903 |
Monika Klempaiová1, Jana Dragúňová2, Peter Kabát3,4, Mária Hnátová1, Ján Koller2, Dušan Bakoš1.
Abstract
In this study we evaluated the biocompatibility of a modified polyurethane nanofiber membrane on a polypropylene spunbond substrate. This material was treated with plasma using diffuse coplanar surface barrier discharge, and subsequent modification was done by continuous spraying of a biologically active chitosan solution (CHIT) containing an inclusion complex of β-cyclodextrin (β-CD) encapsulating berberine (BRB). Biocompatibility was evaluated using several in vitro assays. Human dermal fibroblasts (HDFs) and 3T3 murine fibroblasts were used as biological models. The results of these assays showed that a polyurethane nanofiber membrane modified by CHIT/β-CD/BRB appears to be non-toxic and biocompatible; potentially, it could be used as a wound dressing after further testing.Entities:
Keywords: 3T3 murine fibroblasts; Biocompatibility; Human dermal fibroblasts; Modified polyurethane nanofiber membrane; Plasma treatment
Mesh:
Substances:
Year: 2016 PMID: 27677903 DOI: 10.1007/s10561-016-9585-2
Source DB: PubMed Journal: Cell Tissue Bank ISSN: 1389-9333 Impact factor: 1.522